Form 4 for ARQT Arcutis Biotherapeutics, Inc.
Accepted 2024-07-02 00:00:00 ET · period of report 2024-07-01 · accession 0001787306-24-000108 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-07-02 | 2024-07-01 | ARQT | Welgus Howard G. | Dir | M - OptEx | $1.68 | +10.0K | 186.0K | +6% | +$16.8K |
| D | 2024-07-02 | 2024-07-01 | ARQT | Welgus Howard G. | Dir | S - Sale+OE | $9.31 | -10.0K | 180.3K | -5% | -$93.1K |
| DM | 2024-07-02 | 2024-07-01 | ARQT | Welgus Howard G. | Dir | M - OptEx | $0.00 | -10.0K | 6,614 | -60% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-07-01 | M | A | 4,319 | $1.68 | 190,339 | D | — | — | |
| 2 | Common | Common Stock | 2024-07-01 | M | A | 5,681 | $1.68 | 186,020 | D | — | — | |
| 3 | Common | Common Stock | 2024-07-01 | S | D | 10,000 | $9.31 | 180,339 | D | — | — | |
| 4 | Derivative | Stock Option (right to buy) | 2024-07-01 | M | D | 5,681 | $0.00 | 0 | D | $1.68 · — to 2029-03-13 | 5,681 Common Stock | (F3) This option is fully vested. |
| 5 | Derivative | Stock Option (right to buy) | 2024-07-01 | M | D | 4,319 | $0.00 | 6,614 | D | $1.68 · — to 2029-03-13 | 4,319 Common Stock | (F3) This option is fully vested. |